Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76176 - 76200 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Exisulind	Investigational	HPGD	3248	upregulated	sulindac sulfone results in increased expression of HPGD mRNA	4q34.1	A22282
Exisulind	Investigational	NGFR	4804	upregulated	sulindac sulfone results in increased expression of NGFR mRNA	17q21.33	A21574
Exisulind	Investigational	NQO1	1728	upregulated	sulindac sulfone results in increased expression of NQO1 mRNA	16q22.1	A24353
Exisulind	Investigational	PGR	5241	downregulated	sulindac sulfone results in decreased expression of PGR mRNA	11q22.1	A24359
Exisulind	Investigational	PPARA	5465	upregulated	sulindac sulfone results in increased expression of PPARA mRNA	22q13.31	A24360
Exisulind	Investigational	PPARD	5467	upregulated	sulindac sulfone results in increased expression of PPARD mRNA	6p21.31	A24360
Exisulind	Investigational	PPARG	5468	upregulated	sulindac sulfone results in increased expression of PPARG mRNA	3p25.2	A24360
Exisulind	Investigational	PTGS2	5743	upregulated	sulindac sulfone results in increased expression of PTGS2 mRNA	1q31.1	A24360
Exisulind	Investigational	SAT1	6303	upregulated	sulindac sulfone results in increased expression of SAT1 mRNA	Xp22.11	A11952 A20962
Exisulind	Investigational	TNFRSF10B	8795	upregulated	sulindac sulfone results in increased expression of TNFRSF10B mRNA	8p21.3	A24361
Exisulind	Investigational	UGT1A1	54658	upregulated	sulindac sulfone results in increased expression of UGT1A1 mRNA	2q37.1	A24353
Sulprostone	Investigational	EGR1	1958	upregulated	sulprostone results in increased expression of EGR1 mRNA	5q31.2	A24362
Sulprostone	Investigational	VEGFC	7424	upregulated	sulprostone results in increased expression of VEGFC mRNA	4q34.3	A24362
Sumatriptan	Approved Investigational	NR0B2	8431	downregulated	Sumatriptan results in decreased expression of NR0B2 mRNA	1p36.11	A20438
Sunitinib	Approved Investigational	COL1A1	1277	downregulated	sunitinib results in decreased expression of COL1A1 mRNA	17q21.33	A23660
Sunitinib	Approved Investigational	CYP1A1	1543	upregulated	sunitinib results in increased expression of CYP1A1 mRNA	15q24.1	A24363
Sunitinib	Approved Investigational	FADS2	9415	upregulated	sunitinib results in increased expression of FADS2 mRNA	11q12.2	A21777
Sunitinib	Approved Investigational	HMGCS1	3157	upregulated	sunitinib results in increased expression of HMGCS1 mRNA	5p12	A21777
Sunitinib	Approved Investigational	POLG	5428	downregulated	sunitinib results in decreased expression of POLG mRNA	15q26.1	A24364
Suprofen	Approved Withdrawn	GCLC	2729	upregulated	Suprofen results in increased expression of GCLC mRNA	6p12.1	A23029
Suprofen	Approved Withdrawn	GCLM	2730	upregulated	Suprofen results in increased expression of GCLM mRNA	1p22.1	A23029
Suramin	Investigational	SHC1	6464	upregulated	Suramin results in increased expression of SHC1 mRNA	1q21.3	A22851
Liothyronine	Approved Investigational Vet Approved	ACBD4	79777	downregulated	Triiodothyronine results in decreased expression of ACBD4 mRNA	17q21.31	A20648
Liothyronine	Approved Investigational Vet Approved	ADAM12	8038	upregulated	Triiodothyronine results in increased expression of ADAM12 mRNA	10q26.2	A20648
Liothyronine	Approved Investigational Vet Approved	ADAM15	8751	downregulated	Triiodothyronine results in decreased expression of ADAM15 mRNA	1q21.3	A20648

Displaying entries 76176 - 76200 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability